Virbac Reports Solid Growth in 2025 First Half Results

Virbac has announced a 5.6% revenue growth in the first half of 2025, driven by organic sales, excluding exchange rate variations. The company's adjusted recurring operating income accounted for 18.3% of revenue, aligning with expectations despite phasing and one-off effects reducing profits from 2024 levels.

In Europe, revenue grew by 7.1%, benefiting from increases in Western and Eastern European markets. North America saw a 5.9% increase, while Latin America experienced 8.2% growth due to higher companion and livestock animal sales. Despite declining performance in Chile and the Pacific, Virbac maintains a positive outlook for 2025, with expected growth between 4% and 6%.

The company also anticipates a steady adjusted operating income ratio of 16%. The acquisition of Sasaeah in Japan contributes an additional growth point, expected to be neutral on operating income. Virbac remains optimistic on their cash position and operational investments.